Skip to content

Momentum is building for continuous coating

Charlie Cunningham, Colorcon, says continuous coating by far outperforms traditional batch coating and is fast catching on with pharmaceutical customers.

Momentum is building for continuous coating
Published: | 3 min read

Charlie Cunningham, Colorcon, says continuous coating by far outperforms traditional batch coating and is fast catching on with pharmaceutical customers.

Continuous coating is rapidly becoming more than a niche technology for high volume products. In March 2015, at the 50th American Association of Pharmaceutical Scientists (AAPS) Arden Conference, focus was set on the continuous manufacture of tablets, capsules and other oral solid dosage (OSD) forms. Speakers from many of the largest global pharmaceutical companies as well as the US Food and Drug Administration discussed the benefits and challenges of continuous manufacturing and initiatives supporting this bold shift in the manufacture of OSD forms. 

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information